Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed-dose losartan + hydrochlorothiazide for endothelial function in uncontrolled hypertension on low-dose amlodipine (FCLH)
jRCT1091220222Recruiting
- Sponsor
- Bonpei Takase
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of losartan and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Bonpei Takase. Primary endpoint: Endothelial function. Started Aug 2015; status: recruiting.
02
Drugs
losartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT1091220222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220222.